<DOC>
	<DOCNO>NCT01471925</DOCNO>
	<brief_summary>A phase III , randomize , open-label , superiority study compare incremental product esomeprazole associate sodium bicarbonate make Eurofarma Nexium® treatment gastroesophageal reflux disease . The study enroll 94 patient arm ( total 188 patient ) .</brief_summary>
	<brief_title>Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma Esomeprazole Treatment Gastroesophageal Reflux Disease ESOBIC</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>ICF signing ; Age ≥ 18 year ; Gastroesophageal reflux disease diagnosis ; Grade 0 grade III reflux esophagitis , assess mean upper gastrointestinal endoscopy ; Ability endoscopy , pHmetry esophageal manometry examination perform ; Washout period 1 week without use PPI , H2 antagonists prokinetic agent least 1 day without use antacid . Presence esophagitis require intervention ( grade IV ) , esophageal varix , Barrett 's esophagus , systemic sclerosis ulcer ( gastric duodenal ulcer ) ; Previous gastric esophageal surgery ; Dietary sodium restriction , metabolic alkalosis , hypokalemia , Barter syndrome ; Pregnancy breastfeeding ; Concomitant diseases , kidney , liver heart failure ; Suspected confirm cancer type ; Abusive drug alcohol use ; Abnormal value white blood cell , platelet hemoglobin ; Significant change serum sodium , potassium , calcium creatinine concentration ; Treatment PPI , H2 antagonists prokinetic agent may withhold washout period 1 week study ; Intolerance allergy component drug product assess study ; Use nonsteroidal antiinflammatory drug ( NSAIDs ) , antiemetic agent , macrolide antibiotic systemic corticoid period equal great 2 week study expect require prolong use study treatment ; Concomitant use requirement gastric pHdependent medication optimal absorption ; Scheduled use medication metabolize cytochrome CYP study ; History active peptic ulcer ; Rare hereditary problem fructose intolerance , glucosegalactose malabsorption sucroseisomaltase insufficiency ; Recent participation ( within last 12 month ) another clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>